摘要
目的探讨急诊内科用于治疗老年重症心力衰竭的临床疗效。方法选取本院2014年3月~2016年5月收治的96例老年重症心力衰竭患者,将其随机分为对照组(n=48)和观察组(n=48),对照组采用强心剂、利尿剂等常规疗法,观察组在此基础上给予美托洛尔、厄贝尔沙坦氢氯噻嗪进行治疗,对比两组患者临床疗效。结果观察组经过治疗1年后心功能等级(2.24±0.19)明显小于对照组(3.46±0.11)(P<0.05);观察组治疗有效率95.83%明显高于对照组的81.25%(P<0.05)。结论采用美托洛尔、厄贝尔沙坦氢氯噻嗪联合疗法为老年重症心力衰竭患者加以治疗,临床效果显著,值得推广。
Objective To explore the clinical efficacy of emergency internal medicine for the treatment of elderly patients with severe heart failure.Methods In our hospital from March 2014 to May 2016 were 96 cases of elderly patients with severe heart failure patients were randomly divided into control group(n=48) and observation group(n=48),the control group using cardiotonic,diuretic and other conventional therapy,the observation group was given based on metoprolol,Irbesartan and Hydrochlorothiazide treatment,compared the clinical efficacy of the two groups of patients.Results After 1 years of treatment,the cardiac function level of the observation group(2.24±0.19) was significantly lower than that of the control group(3.46±0.11)(P<0.05),and the effective rate of the observation group was 95.83%,which was significantly higher than that of the control group 81.25%(P<0.05).Conclusion Metoprolol,Irbesartan and Hydrochlorothiazide combined therapy for elderly patients with severe heart failure,the clinical effect is significant,it is worth promoting.
出处
《当代医学》
2018年第6期71-73,共3页
Contemporary Medicine
关键词
急诊内科
老年重症心力衰竭
美托洛尔
厄贝尔沙坦氢氯噻嗪
Emergency internal medicine
Elderly patients with severe heart failure
Metoprolol
Irbesartan and Hydrochlorothiazide
